Plasminogen activator activity in preterm infants with respiratory distress syndrome: Relationship to the development of bronchopulmonary dysplasia

Pediatric Research

Volumn 39, Issue 2, 1996, Pages 229-235

  Singhal, Kamal K ^a   Parton, Lance A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;

ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FIBRINOLYSIS; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RISK ASSESSMENT;

EID: 0030052568     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199602000-00007     Document Type: Article

References (35)

1. Morales WJ, O'Brian WF, Angel JL, Knuppel RA, Sawai S 1989 Fetal lung maturation: the combined use of corticosteroids and thyrotropin-releasing hormone. Obstet Oynecol 7:111-115
2. Morley CJ 1991 Surfactant treatment for premature babies - a review of clinical trials. Arch Dis Child 66:445-450
3. Advance Report of Final Mortality Statistics 1993 Monthly Vital Statistics Report 42(Suppl 2): No. 2
4. Jobe AH 1992 Pathophysiology of respiratory distress syndrome. In: Polin RA, Fox WW (eds) Fetal and Neonatal Physiology. WB Saunders, Philadelphia, pp 995-1001
5. Sitrin RJ 1992 Plasminogen activation in the injured lung: pulmonology does not recapitulate hematology. Am J Respir Cell Mol Biol 6:131-132
6. Gross TJ, Simon RH, Sitrin RG 1990 Expression of urokinase type plasminogen activator by rat pulmonary alveolar epithelial cells. Am J Respir Cell Mol Biol 3:449-456
7. Burkhardt A 1989 Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 140:513-524
8. Senior RM, Skugen WF, Griffin GL, Wilner GD 1986 Effects of fibrinogen derivatives upon the inflammatory response: studies with human fibrinopeptide. J Clin Invest 77:1014-1019
9. Seeger W, Elssner A, Gunther A, Kramer HJ, Kalinowski HO 1993 Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. Am J Respir Cell Mol Biol 9:213-220
10. Colvin RB 1983 Fibrinogen fibrin interactions with fibroblasts and macrophages. Ann NY Acad Sci 408:621-633
11. Saksela O, Rifkin DB 1988 Cell associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93-126
12. Sitrin RG, Brubaker P, Fantone JC 1986 Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities. Am Rev Respir Dis 135:930-936
13. Idell S, Peter J, James K, Fair DS, Coalson JJ 1989 Local abnormalties in coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage. J Clin Invest 84:181-193
14. Idell S, James K, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS 1989 Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the. J Clin Invest 84:695-705
15. Bertozzi P, Astedt B, Zenius L, Lynch K, LeMaire F, Zapol W, Chapman HA Jr. 1990 Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890-897
16. Gross TJ, Simon RH, Kelly CJ, Sitrin RG 1991 Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am J Physiol 260:L286-L295
17. Takahashi K, Kiguchi T, Sawasaki Y, Karikusa F, Nemoto N, Matsuoka T, Yamamoto M 1992 Lung capillary endothelial cells produce and secrete urokinase type plasminogen activator. Am J Respir Cell Mol Biol 7:90-94
18. Loskutoff DJ, Edington TS 1981 An inhibitor of plasminogen activator in rabbit endothelial cells. J Biol Chem 256:4142-4145
19. Parton LA, Warburton D, Lang WE 1992 Plasminogen activator inhibitor type 1 production by rat type II pneumocytes in culture. Am J Respir Cell Mol Biol 6:133-139
20. Chapman HA, Stone OL, Vavrin Z 1984 Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. J Clin Invest 73:806-15
21. McGee MP, Rothberger H 1985 Tissue factor in bronchoalveolar lavage fluids. Evidence for an alveolar macrophage source. Am Rev Respir Dis 131:331-336
22. Vassalli JD, Dayer JM, Wohlwend A, Belin D 1984 Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med 159:1653-1668
23. Edwards DK, Colby TV, Northway WH 1979 Radiographic pathologic correlation in bronchopulmonary dysplasia. J Pediatr 95:834-836
24. Grigg J, Arnon S, Silverman M 1992 Fractional processing of sequential bronchoalveolar lavage fluid from intubated babies. Eur Respir J 5:727-732
25. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG 1986 Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 60:532-538
26. Gordon PA, Strickland S 1986 Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. Biochemistry 25:4033-4040
27. Davis LG, Dibner MD, Battey JF 1986 Basic Methods in Molecular Biology. Elsvier Science Publishing, New York, pp 306-310
28. 4. Nature 227:680-685
29. Avery ME, Mead J 1959 Surface properties in relation to atelactasis and hyaline membrane disease. Am J Dis Child 97:517-523
30. Halliday HL 1991 Surfactant replacement. In: Klaus MH, Fanaroff AA (eds) Yearbook of Neonatal and Perinatal Medicine. Mosby-Year Book, St. Louis, pp xiii-xxi
31. Fowler AA, Hyers TM, Fisher BJ, Bechard DE, Centor RM, and Webster RO 1987 The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk. Am Rev Respir Dis 136:1225-1231
32. Viscardi RM, Broderick K, Sun;CC, Yale-Loehr AJ, Hessamfar A, Taciak V, Burke KC, Koenig KB, Idell S 1992 Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Am Rev Respir Dis 146:492-499
33. 1 proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 72:656-666
34. Bagchi A, Viscardi RM, Taciak V, Hasday JD 1992 Proinflammatory cytokines in lung lavage of infants with RDS. Pediatr Res 31:300A(abstr)
35. Groneck P, Speer BG, Oppermann M, Eiffert H, Speer CP 1994 Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of Inflammatory mediators in respiratory fluids of high risk preterm neonates. Pediatrics 93:712-718